drugset / Trial / NCT01658150
Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder
Completed
11 enrolled
Icahn School of Medicine at Mount Sinai
Brain & Behavior Research Foundation · collab
NaSingle-groupOpen-labelSupportive care
Summary
The purpose of this study is to evaluate the use of the drug isradipine for cognitive enhancement in patients diagnosed with schizophrenia and schizoaffective disorder.
Timeline
- Start
- 2012-09
- Primary completion
- 2018-01-02
- Completion
- 2018-01-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isradipine | Small molecule | — | — |